People on the Move
MRC Technology
UK medical research charity MRC Technology has appointed former AstraZeneca VP and OBE John Stageman as Chairman of the Board.
He will take over from John Jeans, the charity’s Chair for the last six years.
As AstraZeneca’s Vice President of UK Science Affairs, Stageman recently led the team responsible for developing the company’s competitive biopharmaceutical strategy, resulting in the acquisitions of Cambridge Antibody Technology and MedImmune.
He has also served as General Manager of MedImmune Cambridge, Chair of the HealthTech and Medicines Knowledge Transfer Network for the Technology Strategy Board (TSB) and a Council member of the Biotechnology and Biological Sciences Research Council (BBSRC). He was awarded the OBE for services to the UK Biotechnology Industry in 2011.